Video
Dr. Chancellor discusses novel regenerative therapy for recurrent SUI
Author(s):
Video Player is loading.
In this video, Michael B. Chancellor, MD, discusses the background, findings and takeaways of the study, “An evaluation of women with persistent or recurrent stress urinary incontinence (SUI) following surgery in a double-bling, randomized, controlled trial comparing safety and efficacy of autologous muscle derived cells for urinary sphincter repair (AMDC-USR) with placebo (PBO),” presented at the 2021 American Urological Association Annual Meeting. Chancellor is a professor and director of neurourology at Oakland University, Royal Oak, Michigan.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Related Videos
Study: Women with SCI are more likely to use indwelling catheters
Andrea Pezzella, MD, URPS, FACOG, discusses Neuspera's integrated sacral neuromodulation system
Considerations for pre-procedure urinalysis, periprocedural antibiotics for onabotA
Post-RP incontinence: Low procedure rates examined
Roger Dmochowski, MD, on quality-of-life outcomes with the Revi System
Amir Patel, MD, on onabotulinumtoxinA injection at the time of HoLEP
Data link incontinence severity to post-radical prostatectomy care
OnabotA for OAB: Enhancing comfort and ensuring adherence
Roger Dmochowski, MD, on real-world persistence with vibegron for OAB
Considerations for patient follow-up after onabotA administration
Related Content
